Endurant Capital Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-25,081
Closed -$1.15M 70
2018
Q3
$1.15M Sell
25,081
-15,707
-39% -$757K 0.51% 43
2018
Q2
$2.41M Buy
40,788
+16,088
+65% +$932K 1.05% 26
2018
Q1
$1.68M Sell
24,700
-5,200
-17% -$389K 0.63% 40
2017
Q4
$2.96M Buy
29,900
+8,500
+40% +$951K 0.9% 41
2017
Q3
$2.56M Buy
21,400
+2,100
+11% +$195K 0.79% 47
2017
Q2
$1.69M Sell
19,300
-10,300
-35% -$576K 0.48% 53
2017
Q1
$1.1M Buy
+29,600
New +$1.08M 0.35% 64
2015
Q3
Sell
-3,700
Closed -$432K 89
2015
Q2
$432K Buy
3,700
+1,400
+61% +$254K 0.13% 89
2015
Q1
$543K Sell
2,300
-600
-21% -$128K 0.18% 82
2014
Q4
$549K Buy
+2,900
New +$643K 0.22% 79

Other funds holding PBYI